Trials / Completed
CompletedNCT01612780
Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Entellus Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to show clinically meaningful improvement in symptom severity after transnasal balloon dilation of the maxillary sinus outflow tract with or without balloon dilation of the frontal or sphenoid sinuses.
Detailed description
This is a prospective, non-randomized, single arm, post-approval study conducted under a common protocol designed to evaluate outcomes following trans-nasal balloon dilation of the maxillary sinus outflow tract with or without concurrent balloon dilation of the frontal or sphenoid sinuses and without any concomitant conventional sinus surgery (ie, uncinectomy, complete or partial ethmoidectomy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | XprESS Multi-Sinus Dilation Tool | Sinus balloon dilation |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-06-06
- Last updated
- 2020-10-22
- Results posted
- 2020-10-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01612780. Inclusion in this directory is not an endorsement.